20.02.2017
- US drugs giant Pfizer has challenged the record £84 million fine imposed by the UK’s Competition and Markets Authority (CMA) for a supply scheme that resulted in a 2,600% price...
30.01.2017
- About 20% of all new drugs will be rationed under tighter cost-cutting plans in the UK’s National Service (NHS), according to reports, which suggest that patients who suffer from...
10.09.2015
- UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
